tiprankstipranks
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
US Market
Want to see RNA full AI Analyst Report?

Compare Atrium Therapeutics, Inc. (RNA) vs. Competitors

6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Atrium Therapeutics, Inc.
$14.41
$223.69M
-3.29
-11.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
PTC Therapeutics
$72.43
$6.11B
-500.37
73.35%
10 Buy
3 Hold
0 Sell
Strong Buy
Crispr Therapeutics AG
$57.99
$5.29B
-9.29
51.72%
11 Buy
3 Hold
1 Sell
Moderate Buy
Rhythm Pharmaceuticals
$88.69
$6.45B
-26.56
55.09%
14 Buy
0 Hold
0 Sell
Strong Buy
Immunovant
$29.30
$5.89B
-10.43
102.38%
11 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RNA
Atrium Therapeutics, Inc.
13.07
-1.68
-11.39%
PTCT
PTC Therapeutics
73.69
27.68
60.16%
MRUS
CRSP
Crispr Therapeutics AG
54.83
17.24
45.86%
RYTM
Rhythm Pharmaceuticals
94.17
35.21
59.70%
IMVT
Immunovant
28.94
14.39
98.90%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts